The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.

Latest news and blogs
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.

2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.

Partnering for progress: a data-driven analysis of NHS-industry partnerships
This world-first research aims to systematically measure how NHS-industry partnerships support improved patient outcomes using data from across the NHS.

Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.

Events

Online Workshop on SMC: How to prepare and submit to SMC | 08-09 September 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.

SAVE THE DATE - ABPI Industry Summit 2025

ABPI response to DSIT spending allocations
The Department for Science, Innovation and Technology (DSIT) has today announced funding for research and development, including in life sciences.

Medicine levy makes the UK un-investable, say pharma leaders
Leaders from across a key growth sector for the government’s upcoming industrial strategy say future UK investment is unlikely unless an unsustainable levy on manufacturers is addressed.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]
Key content hubs

The COP28 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.

As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.

The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
Affiliate events

Online Workshop on SMC: How to prepare and submit to SMC | 08-09 September 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.

SAVE THE DATE - ABPI Industry Summit 2025

ABPI response to DSIT spending allocations
The Department for Science, Innovation and Technology (DSIT) has today announced funding for research and development, including in life sciences.

Medicine levy makes the UK un-investable, say pharma leaders
Leaders from across a key growth sector for the government’s upcoming industrial strategy say future UK investment is unlikely unless an unsustainable levy on manufacturers is addressed.